Table 1 Outcomes for oocytes collected from ovaries
From: Developmental potential of human oocytes matured in vitro followed by vitrification and activation
Patient | Age a | No. viable oocytes collected | IVM to MII for up to 48 h (%) b | No. oocytes survived after warming (%) | No. oocytes activated (%) | No. oocytes further developed (up to 6 days) (%) | Patient diagnosis |
|---|---|---|---|---|---|---|---|
1 | 18 | 9 | 2 | 1 | 1 | 0 | Sex reassignment surgery |
2 | 24 | 19 | 14 | 10 | 7 | 4c | Sex reassignment surgery |
3 | 25 | 11 | 9 | 4 | 3 | 0 | Cystic adnexal mass |
4 | 29 | 4 | 2 | 2 | 2 | 2 | Cystic adnexal mass |
5 | 39 | 5 | 2 | 2 | 1 | 1 | Cystic adnexal mass |
6 | 37 | 5 | 5 | 4 | 3 | 0 | Cervical adenocarcinoma |
7 | 41 | 10 | 5 | 1 | 1 | 1 | Cervical adenocarcinoma |
Total | 63 | 39/63 (61.9%) | 24/39 (61.5%) | 18/24 (75%) | 8/18 (44.4%) | 8/63 (12.7%) | |
P valued | 0.84 | 0.53 | 1.0 | 0.70 |